1. Signaling Pathways
  2. NF-κB
  3. NF-κB

NF-κB (核因子κB)

Nuclear factor-κB; Nuclear factor-kappaB

NF-κB(活化 B 细胞的核因子 κ 轻链增强子)是一种控制 DNA 转录的蛋白质复合物。NF-κB 存在于几乎所有动物细胞类型中,并参与细胞对压力、细胞因子、自由基、紫外线照射、氧化 LDL 以及细菌或病毒抗原等刺激的反应。NF-κB 在调节对感染的免疫反应中起着关键作用。NF-κB 的错误调节与癌症、炎症和自身免疫性疾病、感染性休克、病毒感染和免疫发育不当有关。NF-κB 还与突触可塑性和记忆过程有关。哺乳动物 NF-κB 家族中有五种蛋白质:NF-κB1、NF-κB2、RelA、RelB、c-Rel。

NF-κB (Nuclear factor kappa-light-chain-enhancer of activated B cells) is a protein complex that controls transcription of DNA. NF-κB is found in almost all animal cell types and is involved in cellular responses to stimuli such as stress, cytokines, free radicals, ultraviolet irradiation, oxidized LDL, and bacterial or viral antigens. NF-κB plays a key role in regulating the immune response to infection. Incorrect regulation of NF-κB has been linked to cancer, inflammatory, and autoimmune diseases, septic shock, viral infection, and improper immune development. NF-κB has also been implicated in processes of synaptic plasticity and memory. There are five proteins in the mammalian NF-κB family: NF-κB1, NF-κB2, RelA, RelB, c-Rel.

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-B1640
    Ethacrynic acid

    依他尼酸

    Inhibitor 99.98%
    Ethacrynic acid 具有抗炎抗癌活性。Ethacrynic acid 是一种口服有效的利尿剂。Ethacrynic acid 是谷胱甘肽 S-转移酶 (GSTs)Wnt 信号通路的抑制剂。Ethacrynic acid 是一种放射增敏剂。Ethacrynic acid 可以抑制小鼠气道平滑肌 (ASM) 收缩。 Ethacrynic acid 可以增加眼睛房水流出用于青光眼的研究。
    Ethacrynic acid
  • HY-N0274
    Caffeic acid phenethyl ester

    咖啡酸苯乙酯

    Inhibitor 99.85%
    Caffeic acid phenethyl ester 是一种 NF-κB 抑制剂。
    Caffeic acid phenethyl ester
  • HY-N0680
    Thiamine hydrochloride

    盐酸硫胺素

    Inhibitor 99.97%
    Thiamine hydrochloride (Thiamine chloride hydrochloride) 是必需的微量营养素,作为许多中枢代谢酶的辅因子。Thiamine hydrochloride 可激活 NrF-2/HO-1 并抑制 TLR4NF-κB。Thiamine hydrochloride 具有神经保护和抗炎作用。Thiamine hydrochloride 可用于糖尿病并发症、神经系统疾病、癌症和结肠炎的研究。
    Thiamine hydrochloride
  • HY-18935
    CBL0137 Inhibitor 99.68%
    CBL0137 是一种 curaxin 化合物,是一种组蛋白伴侣促进染色质转录 (FACT) 抑制剂。CBL0137 下调 NF-?B 并激活 p53。CBL0137 可恢复组蛋白 H3 乙酰化和三甲基化。CBL0137 是一种抗癌剂。CBL0137 诱导癌细胞凋亡 (apoptosis)。
    CBL0137
  • HY-N0170
    Indole-3-carbinol

    3-吲哚甲醇

    Inhibitor 98.87%
    Indole-3-carbinol (I3C) 是芳烃受体 (AhR) 的激动剂,为 NF-κBWWP1 (含有 WW 结构域的 E3 连接酶 1) 的抑制剂。
    Indole-3-carbinol
  • HY-W042416
    N,N-Dimethylacetamide

    二甲基乙酰胺

    Inhibitor 99.96%
    N,N-Dimethylacetamide (DMAc) 是一种具有血脑透过性的有机溶剂和 FDA 批准的药物辅料。N,N-Dimethylacetamide 通过抑制 NF-κB 信号通路发挥抗炎活性。N,N-Dimethylacetamide 可用于高脂肪饮食引起的体重增加和阿尔茨海默病的神经炎症的研究。
    N,N-Dimethylacetamide
  • HY-B1773A
    Sodium propionate

    丙酸钠

    Inhibitor 99.0%
    Sodium propionate 是一种口服活性短链脂肪酸。Sodium propionate 可由肠道细菌 (bacteria) 代谢膳食纤维而产生。Sodium propionate 增加 PPAR-γ,抑制 NF-κB 活化、降低 COX-2 表达和 NO 生成。Sodium propionate 诱导凋亡 (Apoptosis) 和自噬 (Autophagy)。Sodium propionate 减轻 HSV-1 诱发的眼角膜炎。Sodium propionate 对胶质母细胞瘤具有抗癌作用。Sodium propionate 具有神经保护、抗氧化和抗炎活性。Sodium propionate 可用于脊髓损伤、阿尔茨海默症研究。
    Sodium propionate
  • HY-N0256
    Hederagenin

    常春藤皂苷元

    Inhibitor 99.95%
    Hederagenin 是三萜皂苷,具有口服活性和抗肿瘤活性。Hederagenin 能够抑制细胞中由于 LPS 刺激引起的 iNOSCOX-2,和 NF-κB 的表达。Hederagenin 还增加癌细胞中 ROS 产生,破坏线粒体膜电位,诱导细胞凋亡 (apoptosis)。Hederagenin 还增加癌细胞对 Cisplatin (HY-17394) 和 Paclitaxel (HY-B0015) 敏感,增强诱导的细胞凋亡。Hederagenin 对酒精性肝损伤也有预防潜力。
    Hederagenin
  • HY-139567
    Afimetoran Inhibitor 99.37%
    Afimetoran (BMS-986256) 是一种口服有效、选择性、生物利用度高的 TLR7/8 拮抗剂。Afimetoran (BMS-986256) 可以抑制 TLR7/8 激活 NF-κB 通路并逆转 TLR7 介导的对类固醇诱导的浆细胞样树突状细胞 (pDC) 细胞凋亡 (apoptosis) 的耐药性。Afimetoran (BMS-986256) 可用于炎症和自身免疫性疾病 (系统性红斑狼疮) 的研究。
    Afimetoran
  • HY-120501
    B022 Inhibitor 99.37%
    B022 是一种有效的选择性的 NF-κB 诱导激酶 (NIK) 抑制剂,Ki 为 4.2 nM,IC50 为 15.1 nM。B022 可保护肝脏免受毒素引起的炎症,氧化应激和伤害。
    B022
  • HY-N0492
    α-Lipoic Acid

    α-硫辛酸

    Inhibitor 99.86%
    α-Lipoic Acid (Thioctic acid) 是一种抗氧化剂,是线粒体酶复合物的重要辅助因子。α-Lipoic Acid 可抑制 NF-κB 依赖性的 HIV-1 LTR 活化。α-Lipoic Acid 诱导内质网应激 (ERS) 介导的肝癌细胞凋亡 (apoptosis)。α-Lipoic Acid 可与 CPUL1 (HY-151802) 合成自组装的纳米聚合体 CPUL1-LA NA,其抗肿瘤效果优于 CPUL1。
    α-Lipoic Acid
  • HY-P0151
    SN50 Inhibitor 99.66%
    SN50是可渗透细胞的 NF-κB 易位抑制剂。
    SN50
  • HY-N0290
    Mangiferin

    芒果苷

    Inhibitor 99.79%
    Mangiferin 是一种 Nrf2 激活剂。Mangiferin 抑制 NF-κB 亚基 p65p50 的核移位。Mangiferin 具有抗氧化、抗糖尿病、抗高尿酸血症、抗病毒、抗癌和抗炎活性。
    Mangiferin
  • HY-P99444
    Astegolimab

    艾特利单抗

    99.00%
    Astegolimab (MSTT 1041A; RG 6149) 是一种人 IgG2 单克隆抗体,可通过靶向 IL-33 受体 ST2 来阻断 IL-33 信号传导。Astegolimab 可降低 p53 表达,并减轻 IL33 导致的 SASP 因子 (例如 IL1αIL6MCP1) 上调。Astegolimab 可减轻 IL33 导致的 p-p65/p65 比率升高。Astegolimab 可阻断 CM 诱导的中性粒细胞胞外陷阱 (NET) 形成。Astegolimab 可用于慢性阻塞性肺疾病 (COPD) 和心肌研究。
    Astegolimab
  • HY-N0629
    Maslinic acid

    山楂酸

    Inhibitor ≥98.0%
    Maslinic acid 可抑制 NF-κB p65 的 DNA 结合活性, 并消除 IκB-α 磷酸化。
    Maslinic acid
  • HY-114544A
    N-3-oxo-dodecanoyl-L-homoserine lactone Activator 99.88%
    N-3-oxo-dodecanoyl-L-Homoserine lactone (3-oxo-C12-HSL) 是一种细菌群体感应信号分子,由铜绿假单胞菌和洋葱状芽孢杆菌复合物菌株产生。群体感应是细菌用来控制基因表达以响应细胞密度增加的调节系统。N-3-oxo-dodecanoyl-L-Homoserine lactone诱导 16HBE 人支气管上皮细胞产生 IL-8
    N-3-oxo-dodecanoyl-L-homoserine lactone
  • HY-135317
    Emavusertib Inhibitor 99.97%
    Emavusertib (CA-4948) 是口服有效的 IRAK4 (IC50=57 nM) 和 FLT3 抑制剂。Emavusertib 可抑制 NF-κBMyD88 信号通路,减少促炎细胞因子(如 IL-6 和 IL-10)的产生,从而表现出抗炎和对癌细胞的抗增殖活性,诱导细胞凋亡 (apoptosis)。Emavusertib 在小鼠模型中表现出抗肿瘤活性。
    Emavusertib
  • HY-P3229
    SN52 Inhibitor 99.82%
    SN52 是一种有效的、竞争性的、细胞通透性的 NF-κB2 抑制剂。SN52 是 SN50 肽的变体,抑制 p52-RelB 异二聚体的核易位。SN52 对前列腺癌细胞有很强的放射增敏作用。SN52 可以用于癌症研究。
    SN52
  • HY-N0029
    Forsythoside B

    连翘酯苷 B

    99.90%
    Forsythoside B 是传统中药植物连翘的叶子中分离的苯乙醇苷。独一味可用于炎症疾病和促进血液循环的研究。Forsythoside B 可抑制 TNF-alphaIL-6IκB, 调节 NF-κB
    Forsythoside B
  • HY-N1913
    Danshensu

    丹参素

    Inhibitor 98.59%
    Danshensu (Dan shen suan A) 是一种具有口服活性的酚类化合物,可诱导 Nrf2/HO-1 激活并抑制 NF-κB 通路。Danshensu 可减少活性氧 (ROS) 的产生,上调抗氧化防御机制并抑制内在的细胞凋亡途径。Danshensu 对 SARS-CoV-2 显示出有效的抗病毒活性,EC50 为 0.97 μM。Danshensu 具有抗氧化、抗凋亡、抗肺部炎症等作用,具有用于 COVID-19、心脑血管等疾病研究的潜力。
    Danshensu
目录号 产品名 / 同用名 应用 反应物种

NF-κB transcription factors are critical regulators of immunity, stress responses, apoptosis and differentiation. In mammals, there are five members of the transcription factor NF-κB family: RELA (p65), RELB and c-REL, and the precursor proteins NF-κB1 (p105) and NF-κB2 (p100), which are processed into p50 and p52, respectively. NF-κB transcription factors bind as dimers to κB sites in promoters and enhancers of a variety of genes and induce or repress transcription. NF-κB activation occurs via two major signaling pathways: the canonical and the non-canonical NF-κB signaling pathways[1]

 

The canonical NF-κB pathway is triggered by signals from a large variety of immune receptors, such as TNFR, TLR, and IL-1R, which activate TAK1. TAK1 then activates IκB kinase (IKK) complex, composed of catalytic (IKKα and IKKβ) and regulatory (NEMO) subunits, via phosphorylation of IKKβ. Upon stimulation, the IKK complex, largely through IKKβ, phosphorylates members of the inhibitor of κB (IκB) family, such as IκBα and the IκB-like molecule p105, which sequester NF-κB members in the cytoplasm. IκBα associates with dimers of p50 and members of the REL family (RELA or c-REL), whereas p105 associates with p50 or REL (RELA or c-REL). Upon phosphorylation by IKK, IκBα and p105 are degradated in the proteasome, resulting in the nuclear translocation of canonical NF-κB family members, which bind to specific DNA elements, in the form of various dimeric complexes, including RELA-p50, c-REL-p50, and p50-p50. Atypical, IKK-independent pathways of NF-κB induction also provide mechanisms to integrate parallel signaling pathways to increase NF-κB activity, such as hypoxia, UV and genotoxic stress.

 

The non-canonical NF-κB pathway is induced by certain TNF superfamily members, such as CD40L, BAFF and lymphotoxin-β (LT-β), which stimulates the recruitment of TRAF2, TRAF3, cIAP1/2 to the receptor complex. Activated cIAP mediates K48 ubiquitylation and proteasomal degradation of TRAF3, resulting in stabilization and accumulation of the NFκB-inducing kinase (NIK). NIK phosphorylates and activates IKKα, which in turn phosphorylates p100, triggering p100 processing, and leading to the generation of p52 and the nuclear translocation of p52 and RELB[2][3].

 

Reference:

[1]. Oeckinghaus A, et al. The NF-kappaB family of transcription factors and its regulation.Cold Spring Harb Perspect Biol. 2009 Oct;1(4):a000034. 
[2]. Taniguchi K, et al. NF-κB, inflammation, immunity and cancer: coming of age. Nat Rev Immunol. 2018 May;18(5):309-324.
[3]. Perkins ND,et al. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 2007 Jan;8(1):49-62.

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform together.

Please try each isoform separately.